脂肪间充质干细胞与甲泼尼龙联合用药对小型猪异体皮肤移植的影响

doi:10.11843/j.issn.0366-6964.2023.08.037

摘要/Abstract

摘要： 旨在探究脂肪间充质干细胞（adipose derived mesenchymal stem cells，ADSCs）与甲泼尼龙（methylprednisolone，MP）联合用药对小型猪异体皮肤移植（allogeneic skin graft，ASG）所产生的免疫排斥反应与创口愈合的影响。对12头小型猪建立同种异体皮肤移植模型，根据术后对异体皮肤移植皮片不同的干预方式，将小型猪随机分为4组：异体皮肤移植组（ASG）、甲泼尼龙组（MP）、脂肪间充质干细胞组（ADSCs）、脂肪间充质干细胞与甲泼尼龙联合用药组（ADSCs+MP）。术前与术后7、14 d采集血液和组织样本，术后即刻及术后7、14、21 d拍照记录移植表皮临床变化情况。通过对移植皮片表观检查、病理组织学检测，血常规以及血清生化，移植皮片组织氧化应激、炎症、再生的指标检测，综合评价4组不同干预方式对小型猪异体皮肤移植所产生的免疫排斥反应与创口愈合方面的影响。从皮片表观与病理学分析可知，ASG组移植皮片存活时间在7 d左右、MP组移植皮片存活时间在7~14 d、ADSCs组与ADSCs+MP组存活时间为14~21 d。并且在7、14 d时ADSCs+MP组的GSH、SOD的表达量显著升高，在免疫排斥方面，ADSCs+MP组的CD4⁺T细胞的数量，NF-κB的蛋白与基因表达量，IL-2、IFN-γ、TNF-α、IL-1β、IL-6促炎因子的表达量相对于ASG组显著降低。在创口愈合方面，ADSCs+MP组相对于ASG组VEGF、TGF-β的蛋白表达，SDF-1、CXCR4的表达显著上升。并且ADSCs+MP组相对于ASG组，PI3K、AKT、11β-HSD1的蛋白与基因的表达量显著降低。综上所述：ADSCs+MP组相对于ASG组与MP组，可以延长移植皮片存活时间。并且ADSCs+MP可以有效通过促进GSH、SOD的表达抑制氧化应激。在排异方面，ADSCs+MP可以通过抑制NF-κB的表达抑制IL-2、IFN-γ、IL-6、TNF-α等炎性因子的表达，从而抑制移植过后的免疫排斥反应。并且ADSCs+MP可以通过促进VEGF、TGF-β等愈合因子的表达促进创口愈合。进一步研究发现ADSCs可能通过PI3K/AKT来影响11β-HSD1的表达，进而抑制皮肤皮质醇含量，并促进TGF-β、VEGF等生长因子的表达来促进创口肉芽组织再生与血管迁移。

关键词: 小型猪, 脂肪间充质干细胞, 异体皮肤移植, 免疫排斥反应, 创伤愈合, 甲泼尼龙

Abstract: The aim of this experiment was to investigate the effect of the combination of adipose derived mesenchymal stem cells (ADSCs) and methylprednisolone (MP) on immune rejection and wound healing in allogeneic skin grafts from miniature pigs. An allogeneic skin graft model was established for 12 minipigs, and the minipigs were randomly and equally divided into four groups according to different postoperative interventions on allogeneic skin graft skin pieces:allogeneic skin graft group (ASG), methylprednisolone group (MP), adipose mesenchymal stem cells (ADSCs), and combined adipose mesenchymal stem cells and methylprednisolone (ADSCs+MP) group.Blood and tissue samples were collected preoperatively and at 7 and 14 d postoperatively, and clinical changes of the grafted epidermis were photographed and recorded immediately, at 7, 14 and 21 d postoperatively. The effects of the four different interventions on the immune rejection and wound healing of allogeneic skin grafts in minipigs were evaluated by the phenological examination, pathological histological examination, blood and serum biochemistry, and the indexes of oxidative stress, inflammation and regeneration of the grafted skin tissues. From the skin slice phenotypic and pathological analysis, it was observed that the survival time of the grafted skin slice was around 7 d in the ASG group, 7-14 d in the MP group, and 14-21 d in the ADSCs and ADSCs+MP groups. and the expression of GSH and SOD was significantly higher in the ADSCs+MP group at 7 and 14 d. In terms of immune rejection, the ADSCs+MP group had significantly higher CD4⁺ T cells, protein and gene expression of NF-κB, and expression of IL-2, IFN-γ, TNF-α, IL-1β, and IL-6 pro-inflammatory factors were significantly lower in the ADSCs+MP group relative to the ASG group.In terms of wound healing, the ADSCs+MP group significantly increased the protein expression of VEGF and TGF-β, and the expression of SDF-1 and CXCR4 relative to the ASG group. the ADSCs+MP group could significantly inhibit the protein and gene expression of PI3K, AKT, and 11β-HSD1. In conclusion, the ADSCs+MP group could prolong the survival time of grafted skin pieces relative to the ASG and MP groups. And ADSCs+MP could effectively inhibit oxidative stress by promoting the expression of GSH and SOD. In terms of rejection, ADSCs+MP can inhibit the expression of inflammatory factors such as IL-2, IFN-γ, IL-6 and TNF-α by suppressing the expression of NF-κB, thus suppressing the immune rejection reaction after transplantation. Moreover, ADSCs+MP could promote wound healing by promoting the expression of healing factors such as VEGF and TGF-β. Further study revealed that ADSCs may affect the expression of 11β-HSD1 by inhibiting PI3K/AKT, which in turn suppresses skin cortisol content and promotes the expression of growth factors such as TGF-β and VEGF to promote wound granulation tissue regeneration and vascular migration.

Key words: mini-pigs, adipose mesenchymal stem cells, allogeneic skin grafts, immune rejection, wound healing, methylprednisolone

中图分类号:

S857.132

焦广明, 吕英光, 桑金芳, 寇志鹏, 刘涛, 王月, 陆翔宇, 朴晨曦, 马亚军, 张建涛, 王洪斌. 脂肪间充质干细胞与甲泼尼龙联合用药对小型猪异体皮肤移植的影响[J]. 畜牧兽医学报, 2023, 54(8): 3533-3545.

JIAO Guangming, LÜ Yingguang, SANG Jinfang, KOU Zhipeng, LIU Tao, WANG Yue, LU Xiangyu, PIAO Chenxi, MA Yajun, ZHANG Jiantao, WANG Hongbin. Effect of Adipose Mesenchymal Stem Cells in Combination with Methylprednisolone on Allogeneic Skin Grafts in Minipigs[J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(8): 3533-3545.

参考文献 30

[1]	SCHLOTTMANN F, BUCAN V, VOGT P M, et al. A short history of skin grafting in burns:from the gold standard of autologous skin grafting to the possibilities of allogeneic skin grafting with immunomodulatory approaches[J]. Medicina (Kaunas), 2021, 57(3):225.
[2]	GOOPTU M, KORETH J. Translational and clinical advances in acute graft-versus-host disease[J]. Haematologica, 2020, 105(11):2550-2560.
[3]	CLIMOV M, MATAR A J, FARKASH E A, et al. Survival of allogeneic self-assembled cultured skin[J]. Transplantation, 2016, 100(10):2071-2078.
[4]	UENO P, FELIPE C, FERREIRA A, et al. Wound healing complications in kidney transplant recipients receiving Everolimus[J]. Transplantation, 2017, 101(4):844-850.
[5]	BOOTUN R. Effects of immunosuppressive therapy on wound healing[J]. Int Wound J, 2013, 10(1):98-104.
[6]	HAHNENKAMP K, BÖHLER K, WOLTERS H, et al. Organ-protective intensive care in organ donors[J]. Dtsch Arztebl Int, 2016, 113(33-34):552-558.
[7]	ANUDEEP T C, JEYARAMAN M, MUTHU S, et al. Advancing regenerative cellular therapies in non-scarring alopecia[J]. Pharmaceutics, 2022, 14(3):612.
[8]	LI C, WEI S Q, XU Q C, et al. Application of ADSCs and their exosomes in scar prevention[J]. Stem Cell Rev Rep, 2022, 18(3):952-967.
[9]	HU J L, KWON S T, KIM S W, et al. Effects of administration route of adipose-derived stem cells on the survival of allogeneic skin grafts in mice[J]. Transplant Proc, 2021, 53(7):2397-2406.
[10]	MAZINI L, ROCHETTE L, ADMOU B, et al. Hopes and limits of adipose-derived stem cells (ADSCs) and mesenchymal stem cells (MSCs) in wound healing[J]. Int J Mol Sci, 2020, 21(4):1306.
[11]	SMAKAJ A, DE MAURO D, ROVERE G, et al. Clinical application of adipose derived stem cells for the treatment of aseptic non-unions:current stage and future perspectives-systematic review[J]. Int J Mol Sci, 2022, 23(6):3057.
[12]	EYLERT G, DOLP R, PAROUSIS A, et al. Skin regeneration is accelerated by a lower dose of multipotent mesenchymal stromal/stem cells-a paradigm change[J]. Stem Cell Res Ther, 2021, 12(1):82.
[13]	胡俊西. 巴马小型香猪皮肤比较生物学研究[D]. 重庆:西南大学, 2006.HU J X. Comparative biological research of skin in Bama minipig[D]. Chongqing:Southwest University, 2006. (in Chinese)
[14]	陈俊颖, 魏泓. 猪皮肤在创伤修复中的应用研究进展[J]. 西南国防医药, 2009, 19(11):1151-1153.CHEN J Y, WEI H. Research progress on the application of porcine skin in trauma repair[J]. Medical Journal of National Defending Forces in Southwest China, 2009, 19(11):1151-1153. (in Chinese)
[15]	CENDALES L C, KANITAKIS J, SCHNEEBERGER S, et al. The Banff 2007 working classification of skin-containing composite tissue allograft pathology[J]. Am J Transplant, 2008, 8(7):1396-1400.
[16]	LUO L, LI C W, WU W Q, et al. Functional analysis of alloreactive memory CD4+ T cells derived from skin transplantation recipient and naive CD4+ T cells derived from untreated mice[J]. J Surg Res, 2012, 176(2):649-656.
[17]	RICHTERS C D, HOEKSTRA M J, DU PONT J S, et al. Immunology of skin transplantation[J]. Clin Dermatol, 2005, 23(4):338-342.
[18]	BENICHOU G, YAMADA Y, YUN S H, et al. Immune recognition and rejection of allogeneic skin grafts[J]. Immunotherapy, 2011, 3(6):757-770.
[19]	WYNN T A, VANNELLA K M. Macrophages in tissue repair, regeneration, and fibrosis[J]. Immunity, 2016, 44(3):450-462.
[20]	AITCHESON S M, FRENTIU F D, HURN S E, et al. Skin wound healing:normal macrophage function and macrophage dysfunction in diabetic wounds[J]. Molecules, 2021, 26(16):4917.
[21]	LOGIE J J, ALI S, MARSHALL K M, et al. Glucocorticoid-mediated inhibition of angiogenic changes in human endothelial cells is not caused by reductions in cell proliferation or migration[J]. PLoS One, 2010, 5(12):e14476.
[22]	LANGENDORF E K, ROMMENS P M, DREES P, et al. Dexamethasone Inhibits the pro-angiogenic potential of primary human myoblasts[J]. Int J Mol Sci, 2021, 22(15):7986.
[23]	FUJIO K, KOMAI T, INOUE M, et al. Revisiting the regulatory roles of the TGF-β family of cytokines[J]. Autoimmun Rev, 2016, 15(9):917-922.
[24]	MORIKAWA M, DERYNCK R, MIYAZONO K. TGF-β and the TGF-β family:context-dependent roles in cell and tissue physiology[J]. Cold Spring Harb Perspect Biol, 2016, 8(5):a021873.
[25]	ZHONG C X, WANG S Z, DANG L, et al. Progress in 11β-HSD1 inhibitors for the treatment of metabolic diseases:a comprehensive guide to their chemical structure diversity in drug development[J]. Eur J Med Chem, 2020, 191:112134.
[26]	TERAO M, MUROTA H, KIMURA A, et al. 11β-Hydroxysteroid dehydrogenase-1 is a novel regulator of skin homeostasis and a candidate target for promoting tissue repair[J]. PLoS One, 2011, 6(9):e25039.
[27]	TIGANESCU A, HUPE M, UCHIDA Y, et al. Increased glucocorticoid activation during mouse skin wound healing[J]. J Endocrinol, 2014, 221(1):51-61.
[28]	DASHTI-KHAVIDAKI S, SAIDI R, LU H. Current status of glucocorticoid usage in solid organ transplantation[J]. World J Transplant, 2021, 11(11):443-465.
[29]	MORGAN S A, SHERLOCK M, GATHERCOLE L L, et al. 11β-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle[J]. Diabetes, 2009, 58(11):2506-2515.
[30]	SHIBAYAMA Y, ALKHOURY C, NEMAZANYY I, et al. Class 3 phosphoinositide 3-kinase promotes hepatic glucocorticoid receptor stability and transcriptional activity[J]. Acta Physiol (Oxf), 2022, 235(1):e13793.